Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-067939
Filing Date
2024-06-04
Accepted
2024-06-03 18:14:28
Documents
11
Effectiveness Date
2024-06-04

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2416197d1_s8.htm S-8 53695
2 EXHIBIT 4.1 tm2416197d1_ex4-1.htm EX-4.1 79756
3 EXHIBIT 4.2 tm2416197d1_ex4-2.htm EX-4.2 103456
4 EXHIBIT 5.1 tm2416197d1_ex5-1.htm EX-5.1 11010
5 EXHIBIT 23.1 tm2416197d1_ex23-1.htm EX-23.1 2839
6 EX-FILING FEES tm2416197d1_exfilingfees.htm EX-FILING FEES 17727
7 GRAPHIC tm2416197d1_ex4-1img001.jpg GRAPHIC 6334
8 GRAPHIC tm2416197d1_ex4-2img001.jpg GRAPHIC 6232
9 GRAPHIC tm2416197d1_s8img001.jpg GRAPHIC 7760
10 GRAPHIC tm2416197d1_ex5-1img001.jpg GRAPHIC 3422
11 GRAPHIC tm2416197d1_ex5-1img002.jpg GRAPHIC 2024
  Complete submission text file 0001104659-24-067939.txt   305804
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279926 | Film No.: 241015357
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)